Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06327763
Other study ID # Ilioinguinal Neurectomy
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2022
Est. completion date June 1, 2023

Study information

Verified date March 2024
Source Zagazig University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

postoperative chronic inguinal pain is a common postoperative complication after open inguinal hernia repair. Chronic inguinal pain is a common complication following open inguinal hernia repair. Ilioinguinal nerve entrapment is a common cause of this chronic pain which may adversely affect the patients' life. Ilioinguinal neurectomy seems to be beneficial in preventing such pain, but it carries the risk for numbness and hypoesthesia.


Recruitment information / eligibility

Status Completed
Enrollment 196
Est. completion date June 1, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 16 Years to 80 Years
Eligibility Inclusion Criteria: - the study included all adult patients operated on for unilateral inguinal hernia by Lichtenstein tension-free mesh hernioplasty with or without ilioinguinal neurectomy. Exclusion Criteria: - patients with recurrent inguinal hernia, bilateral inguinal hernia repair, or huge inguinoscrotal hernia were excluded. Diabetic patients as well as, patients with suspected inguinal hernia recurrence at the time of the questionnaire were excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ilioinguinal nerve section
patients operated on by open inguinal hernioplasty with ilioinguinal neurectomy

Locations

Country Name City State
Egypt yasmine Hegab Zagazig

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary detect postoperative pain using short form inguinal pain questionnaire ask the patient for presence of postoperative pain using short form inguinal pain questionnaire 3 months following operation then continous
See also
  Status Clinical Trial Phase
Completed NCT02232178 - Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant Phase 2
Completed NCT03234374 - Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty Phase 1
Not yet recruiting NCT06258317 - Mesh Fixation Versus Non Fixation in Laparoscopic Inguinal Hernioplasty N/A